Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Redmond DE, Sladek JR, Roth RH, Collier TJ, Elsworth JD, Deutch AY, Haber S (1986) Lancet 1: 1125-7 T cells from patients with Parkinson's disease recognize α-synuclein peptides. Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A (2017) Nature 546: 656-661 Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA (2010) Nat Genet 42: 77-82 Neurobiology. Dopamine's reversal of fortune. Blakely RD (2001) Science 293: 2407-9 Parkinson's disease redefined. Deutch AY (2013) Lancet Neurol 12: 422-3 A channel to neurodegeneration. Deutch AY, Winder DG (2006) Nat Med 12: 17-8 RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ, Levitt P, Wilson CJ, Hamm HE, Surmeier DJ (2006) Nat Neurosci 9: 832-42 Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ (2006) Nat Neurosci 9: 251-9 Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients. Goldstein M, Lieberman AN, Helmer E, Koslow M, Ransohoff J, Elsworth JD, Roth RH, Deutch AY (1988) Ann Neurol 24: 685-8 A cautionary note on the potential benefits of striatal dopamine implants. Deutch AY, During MJ (1990) Ann Neurol 28: 111 Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Marino MJ, Williams DL, O'Brien JA, Valenti O, McDonald TP, Clements MK, Wang R, DiLella AG, Hess JF, Kinney GG, Conn PJ (2003) Proc Natl Acad Sci U S A 100: 13668-73 Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia. Naydenov AV, Vassoler F, Luksik AS, Kaczmarska J, Konradi C (2010) Acta Neuropathol 120: 623-31 Manganese Is Essential for Neuronal Health. Horning KJ, Caito SW, Tipps KG, Bowman AB, Aschner M (2015) Annu Rev Nutr 35: 71-108 Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ (2005) Neurology 64: 545-7 White matter differences between essential tremor and Parkinson disease. Juttukonda MR, Franco G, Englot DJ, Lin YC, Petersen KJ, Trujillo P, Hedera P, Landman BA, Kang H, Donahue MJ, Konrad PE, Dawant BM, Claassen DO (2019) Neurology 92: e30-e39 Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders. Rouse ST, Marino MJ, Bradley SR, Awad H, Wittmann M, Conn PJ (2000) Pharmacol Ther 88: 427-35 Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Fessel JP, Jackson Roberts L (2005) Antioxid Redox Signal 7: 202-9 cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. Andersson M, Konradi C, Cenci MA (2001) J Neurosci 21: 9930-43 Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. Valenti O, Marino MJ, Wittmann M, Lis E, DiLella AG, Kinney GG, Conn PJ (2003) J Neurosci 23: 7218-26 Nigrostriatal and Mesolimbic D Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors. Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH, Claassen DO (2018) J Neurosci 38: 3230-3239 Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus. Poisik OV, Mannaioni G, Traynelis S, Smith Y, Conn PJ (2003) J Neurosci 23: 122-30 Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata. Bradley SR, Marino MJ, Wittmann M, Rouse ST, Awad H, Levey AI, Conn PJ (2000) J Neurosci 20: 3085-94 Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease. Petersen K, Van Wouwe N, Stark A, Lin YC, Kang H, Trujillo-Diaz P, Kessler R, Zald D, Donahue MJ, Claassen DO (2018) Hum Brain Mapp 39: 509-521 Parkinson's disease: autonomic neuronopathy with impaired cardiovascular regulation. Biaggioni I (2007) Hypertension 49: 21-2 Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia. Bychkov ER, Gurevich VV, Joyce JN, Benovic JL, Gurevich EV (2008) Neurobiol Aging 29: 379-96 Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease. Trujillo P, van Wouwe NC, Lin YC, Stark AJ, Petersen KJ, Kang H, Zald DH, Donahue MJ, Claassen DO (2019) Cortex 115: 99-111 Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW (2006) FASEB J 20: 1695-7 PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper. Aboud AA, Tidball AM, Kumar KK, Neely MD, Han B, Ess KC, Hong CC, Erikson KM, Hedera P, Bowman AB (2015) Neurobiol Dis 73: 204-12 Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice. Sanders TH, Jaeger D (2016) Neurobiol Dis 95: 225-37 Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Marino MJ, Conn PJ (2006) Curr Opin Pharmacol 6: 98-102 A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease. Bademci G, Edwards TL, Torres AL, Scott WK, Züchner S, Martin ER, Vance JM, Wang L (2010) Hum Mutat 31: E1767-71 Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, Andrén PE (2004) J Proteome Res 3: 289-95 Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. Kahn E, D'Haese PF, Dawant B, Allen L, Kao C, Charles PD, Konrad P (2012) J Neurol Neurosurg Psychiatry 83: 164-70 Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I (1994) Clin Sci (Lond) 86: 149-58 Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Acta Psychiatr Scand 78: 730-6 Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model. Brown AM, Baucum AJ, Bass MA, Colbran RJ (2008) J Biol Chem 283: 14286-94 Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT (2005) J Biol Chem 280: 42026-35 Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models. Chattopadhyay M, Chowdhury AR, Feng T, Assenmacher CA, Radaelli E, Guengerich FP, Avadhani NG (2019) J Biol Chem 294: 10336-10348 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: an animal model of olivopontocerebellar atrophy-associated parkinsonism. Deutch AY, Rosin DL, Goldstein M, Roth RH (1989) Exp Neurol 105: 1-9 Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. During MJ, Freese A, Deutch AY, Kibat PG, Sabel BA, Langer R, Roth RH (1992) Exp Neurol 115: 193-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.